|
NUVL | Nuvalent, Inc. |
|
|
NUVL | Nuvalent, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.18 |
| Leverage | 9.69% |
| Market Cap | $ 5.1B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -342.5m |
| Margin | -1797.29% |
None